- A proposal was floated to create removable liver organoids that express l-gulonolactone oxidase, restoring human vitamin-C synthesis while allowing 100 % gene-therapy efficiency via FACS and easy removal if side-effects arise.  
- Participants reviewed 2014 rat data showing decellularized/recellularized kidneys produced ~⅓ normal urine, noting that immunosuppression, not tissue construction, remains the main barrier to engineered kidneys.  
- George Church’s group used CRISPR to delete porcine endogenous retroviruses (PERVs) for safer xenotransplantation, prompting speculation about a similar retroviral purge of the human germline to reduce genetic disease load.  
- Brainstorming sessions explored ballistic, magnetofection, nanoinjection, and viral-evolution strategies to deliver megabase-scale DNA into plant or mammalian cells, including DNA-infused frozen emulsions and magnetic nanoparticles.  
- Open hardware designs for a PIN-photodiode-based XRF spectrometer and proton-induced X-ray emission (PIXE) setups were shared, with interest in a handheld alloy identifier using an Am-241 alpha source.  
- ~30 session transcripts from the May 2017 HGP-Write meeting were archived, covering synthetic-bacteria construction, chromosome transfer, humanized animal models, and xenotransplantation, along with linked videos and slides.  
- Google AdWords now rejects ads for CRISPR kits under a policy against “using the product to modify humans,” highlighting tightening regulatory pressure on open biotech tools.  
- Mike Levin’s bioelectric experiments were discussed: altering ion-channel expression (HCN2) in tadpoles reprogrammed organ identity, producing ectopic eyes or legs and even partially rescuing brain-removed embryos.  
- Recent artificial-womb research kept premature lamb fetuses alive for four weeks via a pumpless oxygenator circuit connected to the umbilical cord, sparking debate on whether an “artificial egg” differs from an explanted womb.  
- Half-serious speculation suggested eliminating menopause so women could repeatedly gestate “repair” offspring whose fetal stem cells engraft and rejuvenate maternal organs, extending lifespan and enabling perpetual breast-milk production.